𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer

✍ Scribed by Rishi Nayyar; Rajeev Kumar; Virendra Kumar; Naranamangalam R. Jagannathan; Narmada P. Gupta; Ashok K. Hemal

Book ID
109055735
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
328 KB
Volume
103
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sequence design for magnetic resonance s
Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T
✍ Charles H. Cunningham; Daniel B. Vigneron; Malgorzata Marjanska; Albert P. Chen; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 308 KB

## Abstract Magnetic resonance spectroscopic imaging (MRSI) has proven to be a powerful tool for the metabolic characterization of prostate cancer in patients before and following therapy. The metabolites that are of particular interest are citrate and choline because an increased choline‐to‐citrat

Reduced power magnetic resonance spectro
Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla
✍ Jamie Near; Cesare Romagnoli; Robert Bartha πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 542 KB

## Abstract Proton magnetic resonance spectroscopic imaging (MRSI) of the prostate has been described at 1.5 T and 3 T as a means of localizing prostate cancers with high sensitivity and specificity. This technique could be improved by increasing the field strength further; however, it has not been